4548 Stock Overview
Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Seikagaku Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥881.00 |
52 Week High | JP¥914.00 |
52 Week Low | JP¥726.00 |
Beta | 0.26 |
11 Month Change | 0.57% |
3 Month Change | 18.10% |
1 Year Change | 16.69% |
33 Year Change | -20.42% |
5 Year Change | -28.55% |
Change since IPO | -59.22% |
Recent News & Updates
Shareholder Returns
4548 | JP Pharmaceuticals | JP Market | |
---|---|---|---|
7D | -0.1% | -1.8% | -2.3% |
1Y | 16.7% | 16.5% | 21.0% |
Return vs Industry: 4548 matched the JP Pharmaceuticals industry which returned 16.5% over the past year.
Return vs Market: 4548 underperformed the JP Market which returned 21% over the past year.
Price Volatility
4548 volatility | |
---|---|
4548 Average Weekly Movement | 3.1% |
Pharmaceuticals Industry Average Movement | 3.9% |
Market Average Movement | 3.7% |
10% most volatile stocks in JP Market | 7.3% |
10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4548 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4548's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1947 | 988 | Ken Mizutani | www.seikagaku.co.jp |
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation.
Seikagaku Corporation Fundamentals Summary
4548 fundamental statistics | |
---|---|
Market cap | JP¥48.07b |
Earnings (TTM) | JP¥2.19b |
Revenue (TTM) | JP¥36.21b |
22.0x
P/E Ratio1.3x
P/S RatioIs 4548 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4548 income statement (TTM) | |
---|---|
Revenue | JP¥36.21b |
Cost of Revenue | JP¥19.34b |
Gross Profit | JP¥16.88b |
Other Expenses | JP¥14.69b |
Earnings | JP¥2.19b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 05, 2024
Earnings per share (EPS) | 40.07 |
Gross Margin | 46.60% |
Net Profit Margin | 6.04% |
Debt/Equity Ratio | 0.4% |
How did 4548 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield163%
Payout RatioDoes 4548 pay a reliable dividends?
See 4548 dividend history and benchmarksSeikagaku dividend dates | |
---|---|
Ex Dividend Date | Sep 27 2024 |
Dividend Pay Date | Dec 04 2024 |
Days until Ex dividend | 65 days |
Days until Dividend pay date | 133 days |
Does 4548 pay a reliable dividends?
See 4548 dividend history and benchmarks